Siste oppdateringer

Ped ALL 003acd A2G Mtx 5 g/m2

Gyn 146 DESTINY-Endom01 Arm C Pembrolizumab 400 mg vedlikehold

Gyn 145 DESTINY-Endom01 Arm C KarboAUC5/pakli/pembro 200 mg

Gyn 144 DESTINY-Endomet01 Arm B Pembrolizumab/trastuzumab derux

Gyn 143 DESTINY-Endomet01 Arm A Rilvegostomig/trastuzumab derux

Mage-tarm 191 CORINTH Pembrolizumab 200 mg

Bryst 105ab Karbo AUC1,5/ paklitaksel+trast iv

Bryst 104ab Docetaksel/karbo AUC5/ trastuz iv

Felles 042 EDP, Etoposid/doksorubicin/cisplatin

Blod 539-542 M24-555 Etentamig

Felles 160ab KANDLELIT-014 Cetuksimab

ØNH 015, 016 Cetuksimab

ØNH 005ab Cetuksimab/cisplatin/fluorouracil 1. kur

ØNH 004ab Cetuksimab/fluorouracil/karbo AUC5 2. kur +

ØNH 003ab Cetuksimab/fluorouracil/karboplatin AUC5 1. kur

Mage-tarm 275ab MOUNTAINEER-03 Cetuksimab

Mage-tarm 234-235 EVIDENT Cetuksimab

Mage-tarm 114 FOLFIRI/cetuksimab 500 mg/m2

Mage-tarm 088 Cetuksimab/irinotekan - 21, 2. kur og senere

Mage-tarm 087 Cetuksimab/irinotekan - 21, 1 kur

Mage-tarm 086 Cetuksimab 500 mg/m2 /irinotekan

Mage-tarm 008 FLIRI/cetuksimab 500 mg/m2

Felles 069 Cetuksimab -14, 500 mg/m2

Felles 069 Cetuksimab -14, 500 mg/m2

Felles 115-116, 116b GO42144 Cetuksimab

Mage-tarm 308 Cetuksimab 2. kur og senere

Mage-tarm 307 Cetuksimab 1. kur

Gyn 133abc BEHOLD-2 modul 1A GSK5733584 + dostarlimab

Lunge 100abc SGNB6A-002, hhv. 1,8, 1,5 og 1,25 mg/kg

Gyn 134abc BEHOLD-2 B7-H4 modul 2B GSK5733584 + bevacizumab

Ped ALL 045a IntReALL 2020 SCB1 konsolidering uke 5 og SCB2m konsolidering uke 12, metotreksat/pegaspargase

Blod 539-542 M24-555 Etentamig

Blod 368-370 MAGNETISMM-7 Arm C. Elranatamab Amendment 8

Blod 368-370 MagnetisMM-7 Arm C. Elranatamab Amendment 8

ENDRINGER I CMS - kurer og øvrig innhold

Gyn 141abc MK-2870-033 Pembrolizumab/Sac-TMT div.

Gyn 140 MK-2870-033 Pembrolizumab/paklitaksel/ karboplatin AUC5

Gyn 142 MK 2870-033 Pembrolizumab 200 mg

Blod 114 AlloTx SAA MUD Flu/cy/ATG/TBI

Ped ALL 045b IntReALL 2020 SCB1 konsolidering uke 6, etoposid/syklofosfamid

Felles 020 FLOX, fluorouracil/kalsiumfolinat/oksaliplatin

Urologi 080 LOXO-FG3-22001: Pembrolizumab -21, 200 mg

Blod 271 AlloTx Haplo RIC Hopkins Flu/Cy/TBI/post-tx syklo

Blod 269 AlloTx RIC ATG/tio/flu/cy/TBI/post-tx syklo

Melanom 044-045 NeoLIPA LTX-315, pembrolizumab

Blod 116  ATG fra kanin (Genzyme)

Ped ALL 043ab IntReALL 2020 induksjon SIB uke 1-4

Ped nevrob 027 HR-NBL2/SIOPEN Dinutuksimab (CHO-antistoff GD2)

Ped nevrob 036 Dinutuksimab/topotekan/temozolomid

Ped nevrob 037 Dinutuksimab/irinotekan/temozolomid